New York - June 2016 - Long's Drugs Inc. ("Long's"), a portfolio company of Tailwind Capital, announced that it has acquired Avita Drugs Inc. ("Avita"). Avita is a leading specialty pharmacy serving chronically ill patient populations in Louisiana, Texas, North Carolina, South Carolina and Virginia.
Headquartered in Baton Rouge, Louisiana, Avita operates a network of pharmacies in Louisiana, Texas, and North Carolina that serve the needs of people living with chronic health conditions. The company offers a broad range of differentiated, high-touch solutions to patients and healthcare providers including (i) proprietary adherence programs, (ii) personalized patient counseling and education, (iii) extensive 340 B pharmacy dispensing, administration and reporting services and (iv) comprehensive patient reporting services.
Christi Epps, Chief Executive Officer of Long's, commented, "We are thrilled to partner with the Avita team. Avita is a market leader in the southeast, providing its patients with best-in-class service and care. This acquisition marks the continued expansion of our specialty pharmacy business and we believe it positions Long's for future growth."
About Long's Drugs:
Long's is a comprehensive pharmacy services provider in South Carolina, North Carolina and Georgia. Founded in 1968 as a traditional retail pharmacy, Long's has leveraged its retail footprint to grow a specialty and 340B contract pharmacy business which serves patients with chronic illnesses and complex medical conditions. The company serves on average over 50,000 patients per month across all of its businesses and dispensed approximately 1.7 million prescriptions in 2015. For more information, please visit www.longsrx.com.
About Tailwind Capital:
Tailwind Capital is a leading middle market private equity firm focused on growth-oriented investments in targeted sectors within healthcare, business and industrial services. Tailwind partners with experienced management teams and entrepreneurs to transform businesses through organic growth initiatives, acquisitions, and operational and strategic improvements. Since inception, Tailwind has managed funds with $2 billion of committed equity capital, having invested in 33 portfolio companies and 50 add-on acquisitions.